Terms: = Skin cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
6 results:
1. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
[TBL] [Abstract] [Full Text] [Related]
2. Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.
Wilson MA; Zhong J; Johannet P; Lee Y; Masub N; Wechter T; Moran U; Berman RS; Shapiro RL; Weber J; Pavlick A; Osman I
Melanoma Res; 2020 Oct; 30(5):492-499. PubMed ID: 32804707
[TBL] [Abstract] [Full Text] [Related]
3. Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.
Wohlmuth C; Wohlmuth-Wieser I; May T; Vicus D; Gien LT; Laframboise S
Am J Clin Dermatol; 2020 Apr; 21(2):285-295. PubMed ID: 31784896
[TBL] [Abstract] [Full Text] [Related]
4. Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience.
Snyder BM; Mounessa JS; Fazzari M; Caravaglio JV; Kretowicz A; Braunberger T; Wells K; Dunnick CA; Dellavalle RP; Alkousakis T
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447632
[TBL] [Abstract] [Full Text] [Related]
5. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract] [Full Text] [Related]
6. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
[TBL] [Abstract] [Full Text] [Related]
